Showing 1,241 - 1,260 results of 2,072 for search '(( significant decrease decrease ) OR ( significant progressive decrease ))~', query time: 0.32s Refine Results
  1. 1241

    Table 1_CyTOF reveals platelet subtype changes predicting the efficacy of combined immunotherapy and targeted therapy in liver cancer.docx by Wenjing Wang (181404)

    Published 2025
    “…Notably, this subpopulation decreased with tumor remission and increased with tumor progression.…”
  2. 1242

    Table 1_Advances in sulodexide-based long-term anticoagulation for a myasthenia gravis patient with giant thymoma.docx by Zhou Liu (1506679)

    Published 2025
    “…Considering the significant surgical risks associated with the giant thymoma, adjuvant chemotherapy was initiated. …”
  3. 1243

    DataSheet1_Effects of Qingjin Huatan decoction on pulmonary function and inflammatory mediators in acute exacerbations of chronic obstructive pulmonary disease: a systematic review... by Xuqin Du (8803772)

    Published 2024
    “…Compared to conventional treatment, QHD significantly improved pulmonary function, with increases in FEV1 (MD = 0.30, 95% CI: 0.26 to 0.34, p = 0.000), FVC (MD = 0.34, 95% CI: 0.27 to 0.41, p = 0.000), FEV1/FVC (MD = 6.07, 95% CI: 5.55 to 6.58, p = 0.000), and PaO<sub>2</sub> (MD = 7.20, 95% CI: 4.94 to 9.47, p = 0.000), and a decrease in PaCO<sub>2</sub> (MD = −5.37, 95% CI: 7.99 to −2.74, p = 0.000). …”
  4. 1244

    DataSheet2_Effects of Qingjin Huatan decoction on pulmonary function and inflammatory mediators in acute exacerbations of chronic obstructive pulmonary disease: a systematic review... by Xuqin Du (8803772)

    Published 2024
    “…Compared to conventional treatment, QHD significantly improved pulmonary function, with increases in FEV1 (MD = 0.30, 95% CI: 0.26 to 0.34, p = 0.000), FVC (MD = 0.34, 95% CI: 0.27 to 0.41, p = 0.000), FEV1/FVC (MD = 6.07, 95% CI: 5.55 to 6.58, p = 0.000), and PaO<sub>2</sub> (MD = 7.20, 95% CI: 4.94 to 9.47, p = 0.000), and a decrease in PaCO<sub>2</sub> (MD = −5.37, 95% CI: 7.99 to −2.74, p = 0.000). …”
  5. 1245

    Table1_Effects of Qingjin Huatan decoction on pulmonary function and inflammatory mediators in acute exacerbations of chronic obstructive pulmonary disease: a systematic review and... by Xuqin Du (8803772)

    Published 2024
    “…Compared to conventional treatment, QHD significantly improved pulmonary function, with increases in FEV1 (MD = 0.30, 95% CI: 0.26 to 0.34, p = 0.000), FVC (MD = 0.34, 95% CI: 0.27 to 0.41, p = 0.000), FEV1/FVC (MD = 6.07, 95% CI: 5.55 to 6.58, p = 0.000), and PaO<sub>2</sub> (MD = 7.20, 95% CI: 4.94 to 9.47, p = 0.000), and a decrease in PaCO<sub>2</sub> (MD = −5.37, 95% CI: 7.99 to −2.74, p = 0.000). …”
  6. 1246

    Data Sheet 1_CyTOF reveals platelet subtype changes predicting the efficacy of combined immunotherapy and targeted therapy in liver cancer.zip by Wenjing Wang (181404)

    Published 2025
    “…Notably, this subpopulation decreased with tumor remission and increased with tumor progression.…”
  7. 1247

    Video 2_Efficacy of P62-expressing plasmid in treatment of canine osteoarthritis pain: a pilot study.mp4 by Vladimir Gabai (38129)

    Published 2025
    “…Introduction<p>Osteoarthritis (OA) is a progressive degenerative disease of synovial joints which is highly prevalent in dogs and results in lameness, loss of joint function and mobility, chronic pain, and reduced quality of life. …”
  8. 1248

    Video 3_Efficacy of P62-expressing plasmid in treatment of canine osteoarthritis pain: a pilot study.mp4 by Vladimir Gabai (38129)

    Published 2025
    “…Introduction<p>Osteoarthritis (OA) is a progressive degenerative disease of synovial joints which is highly prevalent in dogs and results in lameness, loss of joint function and mobility, chronic pain, and reduced quality of life. …”
  9. 1249

    Table 1_Characterization of the airway microbiome in preterm infants with bronchopulmonary dysplasia.doc by Zhidan Bao (22418314)

    Published 2025
    “…Previous studies have indicated a significant association between the pulmonary microbiome and various respiratory diseases. …”
  10. 1250

    Video 1_Efficacy of P62-expressing plasmid in treatment of canine osteoarthritis pain: a pilot study.mp4 by Vladimir Gabai (38129)

    Published 2025
    “…Introduction<p>Osteoarthritis (OA) is a progressive degenerative disease of synovial joints which is highly prevalent in dogs and results in lameness, loss of joint function and mobility, chronic pain, and reduced quality of life. …”
  11. 1251

    Supplementary file 1_Mechanical properties of 3D voxel-printed materials for cardiovascular tissue imitation.docx by Joël Illi (21449474)

    Published 2025
    “…The 0%–60% modulus of elasticity decreased to 0.161–0.192 N/mm<sup>2</sup>, displaying anisotropic material behavior. …”
  12. 1252

    Presentation 1_Combination of αCD4 antibody and retinal antigen injection induces long-term disease control in autoimmune uveitis.pptx by Dijie Qiao (22063459)

    Published 2025
    “…Transcriptomic analysis revealed significant downregulation of inflammation-related genes following treatment.…”
  13. 1253

    Data Sheet 1_Case Report: Dual immunomodulatory and hematologic benefits of rituximab in refractory anemia of ANCA-associated vasculitis.docx by Ningjun Shao (20748705)

    Published 2025
    “…Concurrently, MPO-ANCA titers decreased from 1:1280 to 1:80, and pulmonary infiltrates resolved. …”
  14. 1254

    Antibodies used for flow cytometry. by Shanhe Liu (5251313)

    Published 2025
    “…</p><p>Results</p><p>Flow cytometry analysis revealed a significantly higher apoptosis rate in AN-LSCs compared to LSCs (p < 0.0001). …”
  15. 1255

    Primer pairs used for qPCR. by Shanhe Liu (5251313)

    Published 2025
    “…</p><p>Results</p><p>Flow cytometry analysis revealed a significantly higher apoptosis rate in AN-LSCs compared to LSCs (p < 0.0001). …”
  16. 1256

    Image 1_Emphysema-related mortality rates in the U.S. from 1999 to 2022.pdf by Alexandra Brown (225908)

    Published 2025
    “…</p>Discussion<p>Emphysema-related deaths in the United States decreased overall between 1999 and 2022, likely a result of a greater emphasis on health education concerning the significant dangers of smoking and policy changes that made cigarettes less accessible and less affordable, and more available access to resources and support networks.…”
  17. 1257

    Table 1_ddPCR Enhances early diagnosis, treatment, prognosis, and pathogen verification in elderly BSI.docx by Jiayi Peng (7312952)

    Published 2025
    “…Multiple follow-up ddPCR monitoring revealed progressive increases in the number of species and the copies of some (or all) species among patients with poor outcomes, contrasting with decreasing trends in those with favorable outcomes. …”
  18. 1258

    Table 1_Ultrasonographic assessment of optic nerve sheath diameter on the affected and unaffected sides as a predictor of clinical deterioration at discharge in patients with large... by Changlan Li (704841)

    Published 2025
    “…Background and objectives<p>Progressive cerebral edema worsens prognosis in large hemispheric infarction (LHI). …”
  19. 1259

    Data Sheet 1_Global, regional, and national burden of interstitial lung disease in middle-aged and older adults from 1990 to 2021 with projections to 2050: a systematic analysis of... by Long Chen (315739)

    Published 2025
    “…Joinpoint regression analysis revealed that while ASPR and ASIR increased from 1990 to 2010 but subsequently decreased from 2010 to 2021, conversely, ASDR and DALYs increased from 1990 to 2011 before declining after 2011, frontier analysis highlighted Canada, Ireland, the United States, Japan, and the United Kingdom as nations with significant improvement potential. …”
  20. 1260

    Ablation Experiment GradCAM Heatmap. by Chunhua Yang (346871)

    Published 2025
    “…The experimental results demonstrate that when compared to YOLOv10, S-YOLOv10-ASI shows significant improvements across various metrics. Specifically, Bounding Box Regression Loss decreases by over 30% in the training set, while Classification Loss and Bounding Box Regression Loss drop by more than 60% in the validation set. …”